Literature DB >> 24579039

Ureterocolic fistula secondary to a self-expanding retrievable ureteral stent.

George Ransford1, David Pan1, Ahmed Eldefrawy1, Govindarajan Narayanan1, Murugesan Manoharan1.   

Abstract

Self-expanding stents are relatively new in the field of urology and have primarily been used for permanent remodeling of benign or malignant stricture. We are presenting a rare and interesting case of a ureterocolic fistula that formed secondary to placement of an expandable, retrievable metal stent in the ureter. After multiple retrieval efforts, the self-expanding metal stent was finally retrieved and a ureterocolic fistula was appreciated on antegrade pyelography. The patient chose to manage it non-surgically, with routine nephroureteral catheter exchanges, and her creatinine continues to remain stable.

Entities:  

Keywords:  stent; ureter; ureterocolic fistula

Year:  2013        PMID: 24579039      PMCID: PMC3936141          DOI: 10.5173/ceju.2013.02.art33

Source DB:  PubMed          Journal:  Cent European J Urol        ISSN: 2080-4806


INTRODUCTION

Ureterocolic fistulas are a relatively rare phenomenon. While they are most often secondary to obstructing ureteral calculi, other predisposing factors include diverticular disease, radiation, cancer, tuberculosis (pre–1940) and trauma [1, 2, 3]. We present a rare case of ureterocolic fistula that developed secondary to a WallFlex® self–expanding retrievable stent (Boston Scientific, Natick, MA) that was placed to remodel a ureteral stricture. The application of self–expanding stents in urology was borrowed from their use in vascular and biliary stenoses. The initial urologic use of permanent self–expanding stents was to relieve malignant stricture secondary to an extrinsic pressure from a pelvic tumor or lymph node metastasis [4]. Recently, they have been used for ureteroileal anastomotic strictures following radical cystectomy with urinary diversion [5]. However, there is only one other published report of the use of a temporary, retrievable self–expanding stent for ureteral remodeling [6]; the authors experienced failure of the retrieval loop but had no tissue ingrowth after being in place for one month.

CASE REPORT

A 74–year–old female with a history of cervical cancer underwent multiple pelvic surgeries and radiotherapy. Subsequently, the patient developed symptomatic right–sided hydronephrosis secondary to a 6 cm long mid to distal right–sided ureteral stricture. The patient was initially managed by a community physician who had placed a nephroureteral catheter approximately six months before referring the patient to us. Despite the presence of this catheter, the obstruction persisted, and she continued to have significant symptoms and discomfort. Her creatinine remained stable at 0.7 mg/dl and the nuclear renogram demonstrated adequate function at 42% in the right kidney. In view of the persistence of the stricture, a decision was made to insert a 10 mm x 8 cm WallFlex® self–expanding retrievable stent in the mid to distal right ureter (Figure 1). Based on anecdotal evidence and in collaboration with the interventional radiology team at our institution, we thought it may be possible to use this retrievable stent temporarily in order to remodel the strictured segment of ureter. We also believed that the presence of the nephroureteral catheter inside the self–expanding stent would prevent or reduce the chance of luminal stenosis secondary to intimal hyperplasia.
Figure 1

Retrievable stent at insertion.

Retrievable stent at insertion. She presented 8–weeks later for stent removal. During the procedure, the interventional radiology team encountered difficulty removing the WallFlex® stent, a complication that has been described in the past [6]. When the stent was finally retrieved on the third attempt – nearly one year after placement – extensive “debris” was seen within the stent, which was likely a combination of tissue in–growth and encrustation. The patient subsequently had a new nephroureteral catheter put into place, to be exchanged on a routine basis. In a post–operative follow–up appointment, the patient complained of right flank pain and discomfort, as well as malodorous urine – very common symptoms of a ureterocolic fistula [7]. An antegrade pyelogram demonstrated a fistulous connection between the ureter and the sigmoid colon (Figure 2). In consultation with the colorectal team, we recommended an exploratory laparotomy, lysis of adhesions, and repair of the fistulous connection. However, the patient declined active treatment and elected to continue having routine nephroureteral catheter exchanges. Over the next eight months, she continued to have urinary tract infections, but no fecaluria or pneumaturia. Her most recent creatinine, six months ago, was 0.67 mg/dl, and she continues to have an E. coli positive urine culture. On her most recent visit two months ago, the nephroureteral catheter was exchanged for a double–J stent. During that exchange, a retrograde pyelogram was performed but no fistula could be appreciated.
Figure 2

Retrievable stent removed, enterocolic fistula visualized.

Retrievable stent removed, enterocolic fistula visualized.

DISCUSSION

The WallFlex® stent used in this case is a retrievable and more flexible version of the original Wall-STENT®, which seems to be the most widely tested of the self–expandable metal stents for urologic applications [8]. Composed of a platinum core and nitinol encasement, the WallFlex® has a Permalume® covering to resist tissue ingrowth and an integrated retrieval loop to facilitate removal. The use of self–expanding stents does not come without complications [9]. The most frequent complications reported include tissue ingrowth, migration, infection, encrustation, retrieval difficulty, and scarring of the ureter longer than the original stricture. Liatskios et al. believe that the Achilles heel of ureteral metal stents is urothelial hyperplasia, as it leads to progressive luminal loss and relapse of obstruction – usually occurring early in the post–interventional period [5]. Yet, studies have shown that it usually regresses four to six weeks after insertion of the stent [10, 11]. A prior study in animals found that the degree of force exerted on the ureteral wall affects the degree of urothelial hyperplasia [12]. Accordingly, they describe that a nominal diameter of 8 mm is the maximum that should be implanted in order to achieve a balance between sufficient luminal restoration and the induction of hyperplastic narrowing [5]. We believe that the stent used in this case, 8 cm x 10 mm, might have been too large in diameter, which contributed to a more aggressive urothelial hyperplasia. In addition, a greater outward force by the stent on the ureteral wall could have caused an inflammatory reaction, leading to fistula formation. There are case reports in the literature where metal stents used in the biliary tree have caused such fistulas [13, 14]. While the research to date supports the off–label use of permanent metal stents for malignant and benign obstructions, there are no studies examining the temporary or retrievable self–expanding stents. The aforementioned complications, especially retrieval complications, require further study. In our case, the retrieval difficulty certainly could have been due to a combination of device failure and tissue in–growth or encrustation, as the stent had been in place several months longer than anticipated. Future research will need to address this and other complications, while at the same time increasing the number of patients in a given study.
  14 in total

1.  Biliary-duodenal fistula caused by metal stent.

Authors:  C B Hyun; T Bemiller
Journal:  Gastrointest Endosc       Date:  2001-09       Impact factor: 9.427

2.  Spontaneous choledochoduodenal fistula after metallic biliary stent placement in a patient with ampulla of vater carcinoma.

Authors:  Tae Hoon Lee; Sang-Heum Park; Sang Pil Kim; Sae Hwan Lee; Chang-Kyun Lee; Il-Kwun Chung; Hong Soo Kim; Sun-Joo Kim
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

Review 3.  Ureteral metal stents: a tale or a tool?

Authors:  Evangelos N Liatsikos; George C Kagadis; George A Barbalias; Dimitrios Siablis
Journal:  J Endourol       Date:  2005-10       Impact factor: 2.942

4.  Ureterocolic fistula.

Authors:  C C Winter; B E Linderholm; I W Shiraki
Journal:  Am J Surg       Date:  1973-03       Impact factor: 2.565

5.  Spontaneous ureterocolic fistula secondary to calculous pyohydroureteronephrosis.

Authors:  W K Lee; S D Chang; C J Roche; V A Duddalwar; V A Rowley; M G McLoughlin
Journal:  Br J Radiol       Date:  2005-10       Impact factor: 3.039

6.  Ureteral response to the placement of metallic stents: an animal model.

Authors:  A M Thijssen; S F Millward; K T Mai
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

7.  Metallic Wallstents: a new therapy for extrinsic ureteral obstruction.

Authors:  W Pauer; H Lugmayr
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

8.  Metallic stents for malignant and benign ureteric obstruction.

Authors:  M Wakui; S Takeuchi; J Isioka; K Iwabuchi; S Morimoto
Journal:  BJU Int       Date:  2000-02       Impact factor: 5.588

9.  Ureterocolic fistula secondary to colonic diverticulitis.

Authors:  Y Maeda; S Nakashima; T Misaki
Journal:  Int J Urol       Date:  1998-11       Impact factor: 3.369

10.  Clinical experience with ureteral metal stents.

Authors:  Abdulrahman Al Aown; Kyriazis Iason; Kallidonis Panagiotis; Evangelos N Liatsikos
Journal:  Indian J Urol       Date:  2010-10
View more
  2 in total

1.  [Closure of persisting rectourethral fistula after suprasymphyseal adenoma enucleation of the prostate by combining the Bressel-Naujox and gracilis flap procedure].

Authors:  M Reichert; P Schüler; A Stepniewski; G Felmerer; L Trojan; H C von Knobloch
Journal:  Urologie       Date:  2022-09-06

2.  Treatment of urethrorectal fistulas caused by radical prostatectomy - two surgical techniques.

Authors:  Wojciech Polom; Kazimierz Krajka; Tomasz Fudalewski; Marcin Matuszewski
Journal:  Cent European J Urol       Date:  2014-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.